BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
See today's BioWorld Asia
Home
» Bioepis expands into Celltrion territory with Flixabi nod in Europe
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full story,
subscribe
or
sign in
.
Bioepis expands into Celltrion territory with Flixabi nod in Europe
June 1, 2016
By
Haky Moon
No Comments
HONG KONG – South Korean conglomerate Samsung’s biosimilar arm, Samsung Bioepis Co. Ltd., is well under way in expanding its global presence by pushing multiple blockbuster biosimilars into major markets around the world.
BioWorld Asia